Skip to content
DraconiticResearch
Search Sources API
194,220 studies31 sourcesUpdated 55 min ago
Peer-reviewedCC BYOpen forum infectious diseases

Sequential Time to Positivity as a Prognostic Indicator in Persistent Candidemia

Related

  1. Persistent SARS‐CoV‐2 RNA Positivity in a Chronic Lymphocytic Leukaemia Patient for 127 Days After Disease Onset: A Case Report
    Farnoosh Khamseh, Amir‐Hossein Moghtader‐Mojdehi, Zahra Nemati +1
    Respirology Case ReportsPeer-reviewedCC BYFull textInfectious diseaseDOAJ
  2. Association of PON2 and Its S311C Substitution with Tumor Progression and Its Significance as an Immune-Associated Prognostic Indicator in Clear Cell Renal Cell Carcinoma.
    Zhiyu Liu, Wei Yun, Ting Hong +5
    CancersPeer-reviewedCC BYFull textOncologyEurope PMC
  3. Determinants and Prognostic Value of Persistent Congestion Assessed by Venous Excess Ultrasound Score in Acute Heart Failure
    Diagnostics (Basel, Switzerland)Peer-reviewedCC BYFull textGeneral medicineEurope PMC
  4. Neutrophil-to-lymphocyte Ratio as a Prognostic Indicator in Patients with Nursing and Healthcare-associated Pneumonia: A Retrospective Study
    Yuki Hiraoka, Takashi Ogasawara, Ei Kishimoto +6
    Internal MedicinePeer-reviewedCC BY-NC-NDFull text1 citedOncologyJ-STAGE
  5. CD20 antibody-based combination therapy may reduces the adverse prognostic impact of M-protein positivity in marginal zone lymphoma.
    Yajun Zhang, Wanqian Hu, Ying Fang +4
    Leukemia research reportsPeer-reviewedCC BY-NC-NDFull textGeneral medicineEurope PMC
BibTeX
@article{anon2026sequential,
  title = {{Sequential Time to Positivity as a Prognostic Indicator in Persistent Candidemia}},
  journal = {Open forum infectious diseases},
  year = {2026},
  month = oct,
  url = {https://europepmc.org/article/PMC/PMC13660687},
  note = {CC BY},
}
RIS
TY  - JOUR
TI  - Sequential Time to Positivity as a Prognostic Indicator in Persistent Candidemia
PY  - 2026
DA  - 2026/10/01
JO  - Open forum infectious diseases
UR  - https://europepmc.org/article/PMC/PMC13660687
SN  - 2328-8957
ER  -